El Granada, CA, United States of America

Peter L Barker

USPTO Granted Patents = 6 

Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 65(Granted Patents)


Company Filing History:


Years Active: 1993-1997

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by Peter L Barker: Pioneering Nonpeptidyl Integrin Inhibitors

Introduction

Peter L Barker, an accomplished inventor based in El Granada, CA, holds six patents to his name, showcasing his significant contributions to the field of biochemistry and pharmacology. His innovative work primarily revolves around the development of nonpeptidyl integrin inhibitors, which have deep implications for the treatment of diseases related to platelet aggregation.

Latest Patents

Barker's most notable patents include a benzodiazepinedione derivative that acts as a nonpeptidyl platelet aggregation inhibitor. This groundbreaking inhibitor demonstrates potent abilities to inhibit fibrinogen binding to the GPIIb-IIIa receptor, which is crucial for platelet aggregation. These therapeutic compositions have the potential to transform treatments for various conditions where inhibiting platelet aggregation is vital. Furthermore, these nonpeptidyl inhibitors are thoughtfully provided in combination with thrombolytics and anticoagulants to enhance their effectiveness in clinical settings.

Career Highlights

Peter contributes to Genentech, Inc., a leading biotechnology company renowned for its focus on developing innovative medicines. His work is pivotal in the realm of integrin inhibitors, where his insights and inventions pave the way for advancements in therapeutic interventions.

Collaborations

In his professional journey, Peter L Barker collaborates with esteemed colleagues such as Brent K Blackburn and Thomas Gadek. Their collective expertise and dedication to innovation foster a collaborative environment that drives the development of cutting-edge medical solutions.

Conclusion

Peter L Barker stands out as a notable inventor, driving advancements in the pharmaceutical field. His innovative work on nonpeptidyl integrin inhibitors reflects a deeper understanding of biochemistry and its applications in disease treatment. As research continues to evolve, Barker's contributions will undoubtedly play a significant role in shaping future therapeutic landscapes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…